Luke Nathaniel Walker - 31 Jan 2025 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
Director
Signature
/s/ Andrea Paul, attorney-in-fact for Luke Walker
Issuer symbol
ZNTL
Transactions as of
31 Jan 2025
Net transactions value
+$24,966
Form type
4
Filing time
04 Feb 2025, 16:43:58 UTC
Previous filing
05 Sep 2024
Next filing
12 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Purchase $24,966 +14,200 +20% $1.76 86,681 31 Jan 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.